CTMC
CTMC is a co-development accelerator formed by Resilience and MD Anderson Cancer Center to fast-track the development and manufacturing of next-generation cell therapies for cancer. Located in the heart of the Texas Medical Center, CTMC combines deep expertise in TIL and CAR-T platforms with integrated manufacturing and regulatory capabilities to accelerate the path from discovery to IND. As a true partner, we work side-by-side with cell therapy innovators – advancing programs into the clinic faster and charting a clear course to commercial readiness.
